Sign in to continue:

Saturday, July 25th, 2026

永泰能源股份回购进展公告:2026年计划回购350万股,金额553万元

永泰能源股份回购进展公告详细解读

核心要点

  • 回购方案首次披露日为2025年12月2日。
  • 回购实施期限为2025年12月22日至2026年12月21日。
  • 预计回购金额区间为3亿元至5亿元人民币。
  • 回购用途为注销股份、减少注册资本。
  • 累计已回购350万股,占总股本比例为0.02%,累计金额为553万元。
  • 实际回购价格区间为1.58元/股。

回购背景及决策过程

永泰能源集团股份有限公司于2025年12月1日和12月22日召开董事会及临时股东大会,审议并通过了以集中竞价交易方式回购公司股份的议案。公司计划使用自有及自筹资金,通过上海证券交易所回购股份,用于注销以减少注册资本。回购总金额不低于3亿元、不超过5亿元,回购价格不高于2.50元/股,回购期限为一年。

回购进展及具体数据

截至2026年4月30日,公司已通过集中竞价方式累计回购3,500,000股,约占总股本的0.02%。回购成交价格均为1.58元/股,总支付金额为5,530,000元(不含交易费用)。

公司表示,上述回购进展符合相关法律法规和公司回购方案的要求,并将继续根据市场情况择机实施回购,同时履行信息披露义务。

对投资者的影响及关注事项

  • 股份注销:回购股份将用于注销,减少注册资本,这无疑会提升每股收益,并可能对股价产生积极影响。
  • 回购价格及进度:当前回购价格为1.58元/股,较回购方案上限2.50元/股有较大空间,若后续回购力度加大,可能刺激市场情绪。
  • 回购资金规模:本次回购资金总额最高可达5亿元,目前仅回购约553万元,后续资金使用及回购进度需持续关注,若大额回购落地,将对股价形成支撑。
  • 信息披露:公司承诺将按规定及时披露回购进展,投资者需密切关注后续公告,掌握最新动态。

结语

永泰能源本次股份回购方案及其进展,尤其是用于注销减少注册资本,属于实质性利好。若后续回购力度加大,对公司基本面和股价均可能产生正面影响。投资者应关注回购资金使用进度及每月披露的相关数据。


免责声明:本文仅供参考,不构成任何投资建议。投资者请结合自身风险偏好,谨慎决策。

Yongtai Energy Group Share Buyback Progress: Detailed Report for Investors

Key Highlights

  • Buyback plan was first disclosed on December 2, 2025.
  • Implementation period: December 22, 2025 to December 21, 2026.
  • Estimated buyback amount: RMB 300 million to RMB 500 million.
  • Buyback purpose: To cancel shares and reduce registered capital.
  • Cumulative shares repurchased: 3.5 million shares, accounting for 0.02% of total share capital, with a total amount of RMB 5.53 million.
  • Actual buyback price range: RMB 1.58/share.

Background and Decision Process

Yongtai Energy Group Co., Ltd. held board meetings and an EGM in December 2025, approving the proposal to repurchase shares via centralised bidding. The company intends to use its own and raised funds to buy back shares on the Shanghai Stock Exchange, for cancellation and capital reduction. The total buyback amount will be no less than RMB 300 million and no more than RMB 500 million, with the buyback price capped at RMB 2.50/share and a one-year execution period.

Buyback Progress and Specific Data

As of April 30, 2026, the company has cumulatively repurchased 3,500,000 shares via centralised bidding, accounting for approximately 0.02% of the total share capital. All purchases were executed at RMB 1.58/share, with total payment of RMB 5,530,000 (excluding transaction fees).

The company stated that the buyback progress complies with relevant laws and the buyback plan requirements. Buyback will continue based on market conditions, and regular disclosure will be maintained.

Investor Impact and Key Considerations

  • Share Cancellation: The repurchased shares will be cancelled and the registered capital reduced, likely improving earnings per share and potentially boosting share price.
  • Buyback Price & Progress: Current buyback price is RMB 1.58/share—well below the plan cap of RMB 2.50/share. If buyback accelerates, market sentiment may be positively affected.
  • Buyback Fund Utilisation: With up to RMB 500 million allocated but only RMB 5.53 million used so far, investors should watch for further buybacks; a substantial buyback could support the share price.
  • Disclosure: The company will disclose buyback progress monthly; investors should monitor announcements for the latest updates.

Conclusion

Yongtai Energy’s buyback plan and progress, especially with shares to be cancelled and capital reduced, are material positives. If buyback activity intensifies, it could have a positive impact on fundamentals and share price. Investors should track buyback fund usage and monthly disclosures for timely information.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should make decisions based on their own risk tolerance.

View 永泰能源 Historical chart here



山鹰国际控股股东股份解除质押及再质押最新公告详解(2026)

山鹰国际控股股份公司:控股股东部分股份解除质押及再质押公告,累计质押比例近半 2026年7月24日,山鹰国际控股股份公司...

江苏华辰变压器关于限制性股票回购注销及2025年度权益分派调整“华辰转债”转股价格公告

江苏华辰变压器股份有限公司限制性股票回购注销完成及“华辰转债”转股价格调整公告详解 江苏华辰发布限制性股票回购注销及...

新疆百花村医药集团2025年度及2026年一季度业绩与现金分红说明会公告及投资者参与指南

新疆百花村医药集团股份有限公司召开2025年度及2026年一季度业绩暨分红说明会公告详解 新疆百花村医药集团股份有限...